支气管扩张伴咯血患者导管栓塞治疗后的远期预后分析  

Long-Term Prognosis of Bronchiectasis Patients with Hemoptysis After Anscatheter Embolization

作　　者：廖伟玲[1] 陈文利[1] 暨铭坚[1] 宫玉翠[1] 李平东[1] 

机构地区：[1]广州医科大学附属第一医院/广州呼吸疾病研究所,广东广州510120

出　　处：《临床医学工程》2015年第3期367-368,共2页Clinical Medicine & Engineering

摘　　要：目的分析支气管扩张伴咯血患者介入治疗后的远期预后,为临床出院指导提供参考依据。方法对诊断为支气管扩张伴咯血的64例患者进行为期1年的远期预后随访,收集临床病例资料,电话随访患者出院后咯血情况及转归。结果 64例患者中,有复发咯血患者34例,无复发咯血患者30例,两组间呼吸道感染及慢性咳嗽比例比较差异具有统计学意义（P〈0.05）。34例复发咯血患者中,治疗后3个月内复发18例,3~6个月复发3例,6个月后复发13例。结论通过高危因素的确立,同时根据不同复发咯血时期给予患者更积极的治疗和针对性的健康教育,可改善远期预后。Objective To analyze the long-term prognosis of bronchiectasis patients with hemoptysis after interventional therapy, so as to provide reference for clinical discharge instructions. Methods 64 cases of bronchiectasis patients with hemoptysis were selected in this study and followed-up for 1 year. The clinical data were collected, and the hemoptysis situation and outcome after discharge were observed by telephone follow-up. Results Among 64 patients, there were 34 patients with recurrent hemoptysis and 30 patients without recurrent hemoptysis, and there were statistically significant differences between two groups in the ratio of respiratory tract infections and the ratio of chronic cough（P〈0.05）. Among 34 patients with recurrent hemoptysis, 18 cases relapsed within 3 months after therapy, 3 cases during 3 ~ 6months after therapy, and 13 cases more than 6 months after therapy. Conclusions Clear risk factors, aggressive treatment and targeted health education can improve the long-term prognosis of bronchiectasis patients with hemoptysis after interventional therapy.

关 键 词：支气管扩张伴咯血 介入治疗 远期预后 

分 类 号：R473.5[医药卫生—护理学]